HCA Healthcare, Inc.

Acute care demand is non-discretionary and underpins stable multi-year volume trends; HCA grew revenues every fiscal year from FY2020 through FY2025, including through the COVID-driven elective-procedure disruption of 2020. There is no disclosed backlog or contract retention rate, so forward visibility rests on demographic demand and payer program continuity rather than formally contracted commitments.

HCA serves a range of clinical specialties across inpatient and outpatient settings (outpatient was 38% of patient revenues in FY2025), spanning surgery, emergency, behavioral health, and maternity. All service lines converge on acute hospital delivery within a single industry, with no genuinely uncorrelated revenue stream providing diversification beyond the healthcare services category.

International revenue from eight hospitals in England represented approximately $1.86B of $75.6B total revenues in FY2025, leaving roughly 97.5% of revenues in the United States. Within the U.S., operations span 19 states with particularly dense concentration in Florida and Texas, amplifying exposure to U.S. healthcare policy changes.

Hospital operations carry a structurally high labor cost base: salaries and benefits totaled $32.9B in FY2025, approximately 43.5% of revenues. Annual capital expenditures of $5.0 to $5.5 billion reflect the physical intensity of expanding and maintaining hospital facilities, limiting the operating leverage that more asset-light businesses can achieve.

The majority of HCA's revenues come from non-discretionary acute care, with managed care contracts (~49% of FY2025 revenues) providing multi-year contractual underpinning and government programs (Medicare plus Medicaid, ~46%) ensuring baseline non-elective volume. Exchange-plan volumes (~10% of FY2025 revenues), now under active policy pressure, represent a layer of discretionary-adjacent demand that reduces overall quality at the margin.